The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Cited by (1,000)

Items 401–500 of 1,000

1. Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis
   Minyi Qian, Hai Hu, Ying Yao, Danyang Zhao, Shilei Wang, Chuyue Pan, Xubin Duan, Yingsheng Gao, Jun Liu, Yufei Zhang et al. · 2019 · Liver International
2. Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis
   Domenica Maria Di Palo, Gabriella Garruti, Agostino Di Ciaula, Emilio Molina‐Molina, Harshitha Shanmugam, Maria De Angelis, Piero Portincasa · 2020 · Nutrients
3. Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
   Jin Zhou, Madhulika Tripathi, Rohit A. Sinha, Brijesh Kumar Singh, Paul M. Yen · 2021 · Hepatoma Research
4. Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
   Anshika Jangra, Ashish Kothari, Phulen Sarma, Bikash Medhi, Balram Ji Omar, Karanvir Kaushal · 2022 · Cells
5. MRG15 aggravates non-alcoholic steatohepatitis progression by regulating the mitochondrial proteolytic degradation of TUFM
   Cheng Tian, Xuewen Min, Yongxu Zhao, Yuchen Wang, Xiaoshan Wu, Situn Liu, Wei Dou, Tingting Zhou, Yan Liu, Rongkui Luo et al. · 2022 · Journal of Hepatology
6. Shared Mechanisms between Cardiovascular Disease and NAFLD
   Daniel Q. Huang, Michael Downes, Ronald M. Evans, Joseph Lee Witztum, Christopher K. Glass, Rohit Seth Loomba · 2022 · Seminars in Liver Disease
7. Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
   Anna Gudan, Katarzyna Kozłowska‐Petriczko, Ewa Wunsch, Tomasz Bodnarczuk, Ewa Stachowska · 2023 · Nutrients
8. Escherichia coli Promotes Endothelial to Mesenchymal Transformation of Liver Sinusoidal Endothelial Cells and Exacerbates Nonalcoholic Fatty Liver Disease Via Its Flagellin
   Bo Shen, Tianyi Gu, Zhenyang Shen, Cui Zhou, Yuecheng Guo, Junjun Wang, Binghang Li, Xianjun Xu, Fei Li, Qidi Zhang et al. · 2023 · Cellular and Molecular Gastroenterology and Hepatology
9. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease
   Rohit Sinha, Khalida Ann Lockman, Natalie Z M Homer, Edward Kenneth Merrick Bower, Paul Brinkman, Hugo Knobel, Jonathan Andrew Fallowfield, Alan J. Jaap, Peter Clive Hayes, John N. Plevris · 2020 · JHEP Reports
10. Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis?
    Alexandre Villard, Jérôme Boursier, Ramaroson Andriantsitohaina · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
11. The Toxic Effects of Endocrine Disrupting Chemicals (EDCs) on Gut Microbiota: Bisphenol A (BPA) A Review
    Ioannis Alexandros Charitos, Skënder Topi, Roberto Gagliano-Candela, Emanuele De Nitto, Lorenzo Polimeno, Monica Montagnani, Luigì Santacroce · 2022 · Endocrine Metabolic & Immune Disorders - Drug Targets
12. From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
    Ahmed Mohamed Samy, Mohamed A. Kandeil, Dina Sabry, A.A. Abdel-Ghany, Mohamed O. Mahmoud · 2024 · Heliyon
13. The Role of Intestinal C‐type Regenerating Islet Derived‐3 Lectins for Nonalcoholic Steatohepatitis
    Sena Bluemel, Lirui Wang, Cameron Martino, Suhan Lee, Yanhan Wang, Brandon Williams, Angela Horvath, Vanessa Stadlbauer, Karsten Zengler, Bernd Schnabl · 2018 · Hepatology Communications
14. Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis
    Jin Chen, Ming‐Hua Zheng, Jun Liu, Yan Luo, Wenjun Yang, Jing Yang, Juan Liu, Zhou Jingxing, Chengfu Xu, Faling Zhao et al. · 2019 · Obesity
15. Fecal Fungi Dysbiosis in Nonalcoholic Fatty Liver Disease
    Ningning You, Jiali Xu, Liyan Wang, Lili Zhuo, Jingxin Zhou, Yu Song, Aliaweis Ali, Yan Luo, Jin Yang, Wenjun Yang et al. · 2021 · Obesity
16. Beyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics
    Francesco Ferrara, Sofia Zoupanou, Elisabetta Primiceri, Zulfiqur Ali, Maria Serena Chiriacò · 2021 · Biosensors and Bioelectronics
17. The pathogenic oral–gut–liver axis: new understandings and clinical implications
    Jin Imai, Sho Kitamoto, Nobuhiko Kamada · 2021 · Expert Review of Clinical Immunology
18. Associations of the gut microbiome with hepatic adiposity in the Multiethnic Cohort Adiposity Phenotype Study
    Meredith A.J. Hullar, Isaac Jenkins, Timothy W. Randolph, Keith R. Curtis, Kristine R. Monroe, Thomas M. Ernst, J. Shepherd, Daniel O. Stram, Iona C. Cheng, Bruce S. Kristal et al. · 2021 · Gut Microbes
19. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
    Annette Brandt, Cheng Jun Jin, Katja Nolte, Cathrin Sellmann, Anna Janina Engstler, Ina Bergheim · 2017 · Nutrients
20. Precise species detection of traditional Chinese patent medicine by shotgun metagenomic sequencing
    Tianyi Xin, Chang Su, Yu‐Lin Lin, Shuhong Wang, Zhichao Xu, Jingyuan Song · 2018 · Phytomedicine
21. Obesity genetics and cardiometabolic health: Potential for risk prediction
    Dharambir K. Sanghera, Cynthia Bejar, Sonali Sharma, Rajeev Gupta, Piers R. Blackett · 2019 · Diabetes Obesity and Metabolism
22. Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
    Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, Mario Masarone, Marcello Persico · 2021 · Frontiers in Medicine
23. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH
    Hernandez, Gabriella V., Smith, Victoria A., Melnyk, Megan, Burd, Matthew A., Sprayberry, Kimberly A., Edwards, Mark S., Peterson, Daniel G., Bennet, Darin C., Fanter, Rob K., Columbus, Daniel A. et al. · 2020 · American Journal of Physiology-Gastrointestinal and Liver Physiology
24. Targeting keystone species helps restore the dysbiosis of butyrate‐producing bacteria in nonalcoholic fatty liver disease
    Dingfeng Wu, Lei Liu, Na Jiao, Yida Zhang, Li Yang, Chuan Tian, Ping Lan, Lixin Zhu, Rohit Seth Loomba, Ruixin Zhu · 2022 · iMeta
25. Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Federica Fogacci, Marina Giovannini, Valentina Di Micoli, Elisa Grandi, Claudio Borghi, Arrigo F.G. Cicero · 2024 · Nutrients
26. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage
    Manuela G. Neuman, Samuel William French, Samir Zakhari, Stephen D. H. Malnick, Helmut Karl Seitz, Lawrence B. Cohen, Mikko P. Salaspuro, Andreea Voinea‐Griffin, Andrei Barasch, Irina Kirpich et al. · 2017 · Experimental and Molecular Pathology
27. Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver disease
    Michihiro Iwaki, Takaomi Kessoku, Anna Ozaki, Yuki Kasai, Takashi Kobayashi, Asako Nogami, Yasushi Honda, Yuji Ogawa, Kento Imajo, Masato Yoneda et al. · 2021 · Journal of Gastroenterology and Hepatology
28. The role of microbiota in nonalcoholic fatty liver disease
    Agostino Di Ciaula, Leonilde Bonfrate, Piero Portincasa · 2022 · European Journal of Clinical Investigation
29. Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality
    Xia Yi, Mengting Ren, Jinpu Yang, Changzhou Cai, Weixin Cheng, Xinxin Zhou, Dan Lu, Feng Ji · 2022 · Frontiers in Microbiology
30. Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression
    Julius W. Jaeger, Annette Brandt, Wenfang Gui, Timur Yergaliyev, Angélica María Hernández-Arriaga, Mukil Marutha Muthu, Karolina Edlund, Ahmed Elashy, Antonio Molinaro, Diana Möckel et al. · 2024 · JHEP Reports
31. Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis
    Cathrin Sellmann, Christian Degen, Cheng Jun Jin, Anika Nier, Anna Janina Engstler, Dana Hasan Alkhatib, Jean Pascal De Bandt, Ina Bergheim · 2017 · Amino Acids
32. Microbiota and the liver
    Ting‐Chin David Shen, Nikolaos Pyrsopoulos, Vinod K. Rustgi · 2018 · Liver Transplantation
33. Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis
    Phuong Nguyen, Leila Valanejad, Ashley E. Cast, Mary Wright, José M. Garcia, Hashem B. El‐Serag, Rebekah A. Karns, Nikolai A. Timchenko · 2018 · Cell Reports
34. Mesenteric lymph node CD4+ T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease
    Lin Chong Su, Zhe Wu, Yujing Chi, Yang Song, Jun Xu, Jiang Tan, Cong Xu, Yulan Liu · 2019 · Cellular Immunology
35. Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma
    Noriho Iida, Eishiro Mizukoshi, Tatsuya Yamashita, Takeshi Terashima, Kuniaki Arai, Jun Seishima, Shuichi Kaneko · 2019 · International Journal of Cancer
36. Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy
    Patricia Pringle Bloom, Jesús M. Luévano, Kelsey J. Miller, Raymond T. Chung · 2021 · Annals of Hepatology
37. Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease
    Joo Hyun Oh, Jehee Lee, Min Seok Cho, Hyeree Kim, Jongsik Chun, Joon Hyeok Lee, Yeup Yoon, Wonseok Kang · 2021 · Nutrients
38. Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
    Bo Zhu, Siu‐Lung Chan, Jack Li, Kathryn S. Li, Hao Wu, Kui Cui, Hong Chen · 2021 · Frontiers in Cardiovascular Medicine
39. Research progress on intervention effect and mechanism of protocatechuic acid on nonalcoholic fatty liver disease
    Yunxiao Gao, Rongrong Tian, Haiyue Liu, Huimin Xue, Ruizhe Zhang, Suping Han, Lin Ji, Weidong Huang, Jicheng Zhan, Yilin You · 2021 · Critical Reviews in Food Science and Nutrition
40. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
    Xiaoli Pan, Yanqiao Zhang · 2022 · Chinese Medical Journal
41. Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical Outcomes
    Mohamad Jamalinia, A. Lonardo, Ralf Weiskirchen · 2024 · Fibrosis
42. Pediatric Non-alcoholic Fatty Liver Disease
    Vikas Uppal, Sana Mansoor, Katryn N. Furuya · 2016 · Current Gastroenterology Reports
43. Antimicrobial proteins: intestinal guards to protect against liver disease
    Tim Hendrikx, Bernd Schnabl · 2018 · Journal of Gastroenterology
44. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non‐Alcoholic Fatty Liver Disease
    Petar Petrov, María Victoria García‐Mediavilla, Carla Guzmán, David Porras, Esther Nistal, Susana Martínez‐Flórez, José Vicente Castell, Javier González‐Gallego, Sonia Sánchez‐Campos, Ramiro Jover · 2019 · Molecular Nutrition & Food Research
45. A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
    Paula Iruzubieta, J M Medina, Raúl Fernández-López, Javier Crespo, Fernando de la Cruz · 2020 · Journal of Clinical Medicine
46. Effects of chlorpyrifos exposure on liver inflammation and intestinal flora structure in mice
    Yecui Zhang, Qiang Jia, Chenyang Hu, Mingming Han, Qiming Guo, Shumin Li, Cunxiang Bo, Yu Zhang, Xue‐Jie Qi, Linlin Sai et al. · 2020 · Toxicology Research
47. The Endless Sources of Hepatocellular Carcinoma Heterogeneity
    M. Bárcena-Varela, A. Lujambio · 2021 · Cancers
48. What Is the Role of Gut Microbiota in Obesity Prevalence? A Few Words about Gut Microbiota and Its Association with Obesity and Related Diseases
    Julita Tokarek, Joanna Gadzinowska, Ewelina Młynarska, Beata Franczyk, Jacek Rysz · 2021 · Microorganisms
49. Fecal Microbiota Transplantation in Liver Cirrhosis
    Adrian Boicean, Victoria Bîrluțiu, Cristian Ichim, Olga Brusnic, Danusia Maria Onișor · 2023 · Biomedicines
50. Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma
    Thananya Jinato, Songtham Anuntakarun, Nantawat Satthawiwat, Natthaya Chuaypen, Pisit Tangkijvanich · 2024 · Applied Microbiology and Biotechnology
51. Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications
    Raja Ganesan, Haripriya Gupta, Yoseph Asmelash Gebru, Gi Soo Youn, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Dong Joon Kim, Tae‐Jin Kim, Ki Tae Suk · 2021 · International Journal of Molecular Sciences
52. Lactic acid bacteria alleviate liver damage caused by perfluorooctanoic acid exposure via antioxidant capacity, biosorption capacity and gut microbiota regulation
    Liuting Shi, Ruili Pan, Guopeng Lin, Xi Liang, Jianxin Zhao, Hao Zhang, Wei Chen, Gang Wang · 2021 · Ecotoxicology and Environmental Safety
53. Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics
    Mayumi Nagashimada, Masao Honda · 2021 · International Journal of Molecular Sciences
54. Evaluation of Sample Preservation and Storage Methods for Metaproteomics Analysis of Intestinal Microbiomes
    Angie L. Mordant, Manuel Kleiner · 2021 · Microbiology Spectrum
55. The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
    Yiming Ni, Mengna Lu, Yuan Xu, Qixue Wang, Xinyi Gu, Ying Li, Tongxi Zhuang, Chenyi Xia, Ting Zhang, Xiaojun Gou et al. · 2022 · Frontiers in Microbiology
56. Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism
    Isabel María Cornejo-Pareja, Mohamed Reda Amiar, Luís Ocaña-Wilhelmi, Rocío Soler-Humanes, Isabel Arranz‐Salas, Lourdes Garrido‐Sánchez, Carolina Gutiérrez‐Repiso, Francisco José Tinahones · 2024 · Journal of Gastroenterology
57. Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease
    Huaying Wu, Jingjing Chen, Shuyuan Guo, Jinhao Deng, Zimeng Zhou, Xuan Zhang, Tiantian Qi, Fei Yu, Qi Liang Yang · 2025 · Gut Microbes
58. Microbiota Modulation With Synbiotic Decreases Liver Fibrosis in a High Fat Choline Deficient Diet Mice Model of Non-Alcoholic Steatohepatitis (NASH)
    Helena Cortez‐Pinto, Paula Borralho, Jorge Machado, Teresa Lopes, I. Vale do Gato, António Mário Santos, António Sousa Guerreiro · 2016 · GE Portuguese Journal of Gastroenterology
59. Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis
    Eleonora Scorletti, Christopher D. Byrne · 2016 · Digestive Diseases
60. Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria
    Katherine J. P. Schwenger, Colin M. Bolzon, Carrie Li, Johane P. Allard · 2018 · European Journal of Nutrition
61. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics
    Min Seok Cho, Sang Yeol Kim, Ki Tae Suk, Byung‐Yong Kim · 2018 · The Journal of Microbiology
62. 1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis
    Junping Zheng, Lin Zhu, Baifei Hu, Xiaojuan Zou, Haiming Hu, Zhigang Zhang, Nan Jiang, Jun Ma, Huabing Yang, Hongtao Liu · 2019 · The Journal of Nutritional Biochemistry
63. Short-term dietary restriction in old mice rejuvenates the aging-induced structural imbalance of gut microbiota
    Ting Zeng, Hui Cui, Duozhuang Tang, George B. Garside, Yiting Wang, Jianying Wu, Zhendong Tao, Liu Zhang, Si Tao · 2019 · Biogerontology
64. Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding—A Review of Rodent Models
    Saioa Gómez‐Zorita, Leixuri Aguirre, Iñaki Milton‐Laskibar, Alfredo Fernández‐Quintela, Jenifer Trepiana, Naroa Kajarabille, Andrea Mosqueda-Solís, Marcela Aída González, María P. Portillo · 2019 · Nutrients
65. The gut mycobiome: a novel player in chronic liver diseases
    Lu Jiang, Peter Stärkel, Jian‐Gao Fan, Derrick E. Fouts, Petra Bächer, Bernd Schnabl · 2020 · Journal of Gastroenterology
66. The Influence of the Microbiome on NAFLD and NASH
    Somaya A. M. Albhaisi, Jasmohan Singh Bajaj · 2021 · Clinical Liver Disease
67. Human Gut Microbiome and Liver Diseases: From Correlation to Causation
    Rui Li, Zhengsheng Mao, Xujun Ye, Tao Zuo · 2021 · Microorganisms
68. Trust Your Gut: The Association of Gut Microbiota and Liver Disease
    Ridda Manzoor, Weshah Ahmed, Nariman Afify, Mashal Memon, Maryam Yasin, Hamda Memon, Mohammad Rustom, Mohannad Al Akeel, Noora Alhajri · 2022 · Microorganisms
69. Gut microbiome as a therapeutic target for liver diseases
    Tejinder Pal Singh, Saurabh Kadyan, Harisha Devi, Gwoncheol Park, Ravinder Nagpal · 2023 · Life Sciences
70. Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Emidio Scarpellini, Marialaura Scarcella, Jan F. Tack, Giuseppe Guido Maria Scarlata, Michela Zanetti, Ludovico Abenavoli · 2024 · Antioxidants
71. High-cholesterol diet does not alter gut microbiota composition in mice
    Lidiya G. Dimova, Nikola Zlatkov, Henkjan J. Verkade, Bernt Eric Uhlin, Uwe J.F. Tietge · 2017 · Nutrition & Metabolism
72. Managing diabetes and liver disease association
    Abd Elkhalek Hamed, Medhat Elsahhar, Nadia Mohamed Elwan, Sarah Abdel Kader El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod Sholkamy, Heba Kamal Sedrak, Samir N. Assaad et al. · 2018 · Arab Journal of Gastroenterology
73. Gastrointestinal Microbiome – What We Need to Know in Clinical Practice
    Raquel Ortigão, Pedro Pimentel‐Nunes, Mário Jorge Dinis-Ribeiro, Diogo Libânio · 2020 · GE Portuguese Journal of Gastroenterology
74. Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats
    Larisse Longo, Jéssica Tonin Ferrari, Pabulo Henrique Rampelotto, Gustavo Hirata Dellavia, Amanda Pasqualotto, Claudia Pinto Marques Souza de Oliveira, Carlos Thadeu Schmidt Cerski, Themis Reverbel da Silveira, Carolina Uribe Cruz, Mário Reis Álvares‐da‐Silva · 2020 · Clinical and Experimental Gastroenterology
75. Epigallocatechin Gallate Can Protect Mice From Acute Stress Induced by LPS While Stabilizing Gut Microbes and Serum Metabolites Levels
    Yong Ma, Gang Liu, Muyang Tang, Jun Qun Fang, Hongmei Jiang · 2021 · Frontiers in Immunology
76. Nonalcoholic fatty liver disease and non-liver comorbidities
    Richie Manikat, Mindie H. Nguyen · 2023 · Clinical and Molecular Hepatology
77. Non-pharmacological management options for MAFLD: a practical guide
    José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Altikes, Claudia Pinto Marques Souza de Oliveira · 2023 · Therapeutic Advances in Endocrinology and Metabolism
78. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease
    Benedikt K. Kaufmann, Nick Seyfried, Daniel Hartmann, Phillipp Hartmann · 2023 · American Journal of Physiology-Gastrointestinal and Liver Physiology
79. Ginsenoside Rk3 Regulates Nonalcoholic Steatohepatitis by Modulation of Intestinal Flora and the PI3K/AKT Signaling Pathway in C57BL/6 Mice
    Mengdi Guo, Chenhui Zhu, Rongzhan Fu, Xiaoxuan Ma, Zhiguang Duan, Daidi Fan · 2023 · Journal of Agricultural and Food Chemistry
80. Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics
    Vineet Singh, Kanika Mahra, Da-Ryung Jung, Jae‐Ho Shin · 2024 · Probiotics and Antimicrobial Proteins
81. Microbial modulation of tryptophan metabolism links gut microbiota to disease and its treatment
    Pengfei Zhao, Yuqi Chen, Shuyu Zhou, Fei Li · 2025 · Pharmacological Research
82. Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis
    Machi Atarashi, Takeshi Izawa, Rena Miyagi, Shoko Ohji, Ai Hashimoto, Mitsuru Kuwamura, Jyoji Yamate · 2018 · Nutrients
83. Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease
    Eleonora Scorletti, Paul R. Afolabi, Elizabeth A. Miles, Debbie E. Smith, Amal Almehmadi, Albandri Saleh Alshathry, Helen E. Moyses, Geraldine Frances Clough, Mark Wright, Janisha Patel et al. · 2018 · Contemporary Clinical Trials
84. Gut eukaryotic disease-discriminatory taxa are indicative of Pacific white shrimp (Litopenaeus vannamei) white feces syndrome
    Wenfang Dai, Qiongfen Qiu, Jiong Chen, Jinbo Xiong · 2019 · Aquaculture
85. Effects of chronic cadmium exposure at food limitation-relevant levels on energy metabolism in mice
    Xiwei He, Zhaodong Qi, Hui Hou, Jie Gao, Xuxiang Zhang · 2019 · Journal of Hazardous Materials
86. Mechanisms of nonalcoholic fatty liver disease and implications for surgery
    Benedikt K. Kaufmann, Agustina Reca, Baocai Wang, Helmut Friess, Ariel E. Feldstein, Daniel Hartmann · 2020 · Langenbeck s Archives of Surgery
87. Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
    Kechagias, Stergios, Ekstedt, Mattias, Simonsson, Christian, Nasr, Patrik · 2022 · Hormones
88. A Current Understanding of FXR in NAFLD: The multifaceted regulatory role of FXR and novel lead discovery for drug development
    Yuhong Tang, Yujuan Fan, Yiming Wang, Dong Wang, Qingyu Huang, Tongqing Chen, Xinyue Cao, Cailing Wen, Xiaoyan Shen, Jian Li et al. · 2024 · Biomedicine & Pharmacotherapy
89. Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes
    Michael S. Kriss, Elizabeth C. Verna, Hugo R. Rosen, Catherine Lozupone · 2018 · Transplantation
90. Processed Meat Protein Promoted Inflammation and Hepatic Lipogenesis by Upregulating Nrf2/Keap1 Signaling Pathway in Glrx-Deficient Mice
    Muhammad Ijaz Ahmad, Xiaoyou Zou, Muhammad Umair Ijaz, Muzahir Hussain, Congcong Liu, Xinglian Xu, Guanghong Zhou, Chunbao Li · 2019 · Journal of Agricultural and Food Chemistry
91. Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm
    Uday C. Ghoshal, Amit Goel, Eamonn M.M. Quigley · 2020 · Indian Journal of Gastroenterology
92. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice
    Qiong Li, Meng Li, Fenghua Li, Wenjun Zhou, Yanqi Dang, Li Rita Zhang, Guang Ji · 2020 · Journal of Ethnopharmacology
93. The human symbiont Bacteroides thetaiotaomicron promotes diet-induced obesity by regulating host lipid metabolism
    Sang‐Hyun Cho, Yong‐Joon Cho, Joo‐Hong Park · 2021 · The Journal of Microbiology
94. The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
    Hui Xiang, Dating Sun, Xin Liu, Zhi‐Gang She, Yonghong Chen · 2022 · Frontiers in Endocrinology
95. Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease
    Anastasiia Driuchina, Jukka E. Hintikka, Marko Lehtonen, Pekka Keski‐Rahkonen, Thomas M. O’Connell, Risto Olavi Juvonen, Juho Kuula, Antti Hakkarainen, Jari Antero Laukkanen, Elina Mäkinen et al. · 2023 · mBio
96. Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function
    Josh Bilson, Jaswinder K. Sethi, Christopher D. Byrne · 2021 · Proceedings of The Nutrition Society
97. Upper gut heat shock proteins HSP70 and GRP78 promote insulin resistance, hyperglycemia, and non-alcoholic steatohepatitis
    Giulia Angelini, Lidia Castagneto‐Gissey, Serenella Salinari, ALESSANDRO BERTUZZI, Danila Anello, Meenakshi Pradhan, Marlen Zschätzsch, Paul Ritter, Carel Wynand le Roux, Francesco Rubino et al. · 2022 · Nature Communications
98. Maternal Betaine Supplementation Mitigates Maternal High Fat Diet-Induced NAFLD in Offspring Mice through Gut Microbiota
    Liuqiao Sun, Xuying Tan, Xiaoping Liang, Hangjun Chen, Qian Ou, Qiongmei Wu, Xinxue Yu, Hanqing Zhao, Qiaoli Huang, Zehua Yi et al. · 2023 · Nutrients
99. Alterations of the intestinal microbiota in age-related macular degeneration
    Yuanyuan Zhang, Tianyu Wang, Zhongqi Wan, Jianhao Bai, Yawen Xue, Rushun Dai, Minli Wang, Qing Peng · 2023 · Frontiers in Microbiology
100. Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
     Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo · 2025 · International Journal of Molecular Sciences